Matrix Metalloproteinase-9 Is Involved in Chronic Lymphocytic Leukemia Cell Response to Fludarabine and Arsenic Trioxide

作者: Irene Amigo-Jiménez , Elvira Bailón , Estefanía Ugarte-Berzal , Noemí Aguilera-Montilla , José A. García-Marco

DOI: 10.1371/JOURNAL.PONE.0099993

关键词: MedicineHEK 293 cellsChronic lymphocytic leukemiaArsenic trioxideCell migrationImmunologyChemotherapyLeukemiaCytotoxic T cellFludarabineGeneral Biochemistry, Genetics and Molecular BiologyGeneral Agricultural and Biological SciencesGeneral Medicine

摘要: Background Matrix metalloproteinase-9 (MMP-9) contributes to chronic lymphocytic leukemia (CLL) pathology by regulating cell migration and preventing spontaneous apoptosis. It is not known if MMP-9 involved in CLL response chemotherapy we address this the present study, using arsenic trioxide (ATO) fludarabine as examples of cytotoxic drugs.

参考文章(41)
Leman Yel, Sastry Gollapudi, Sudhir Gupta, Houfen Su, Abdullah Baysan, Arsenic trioxide induces apoptosis via the mitochondrial pathway by upregulating the expression of Bax and Bim in human B cells. International Journal of Oncology. ,vol. 30, pp. 313- 318 ,(2007) , 10.3892/IJO.30.2.313
Angeles Garcia-Pardo, José Garcia-Marco, Mercedes Garcia-Gila, José V Moyano, Laura Sanz, Augusto Silva, Benito Casanova, Maria Teresa de la Fuente, Engagement of α4β1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine Journal of Leukocyte Biology. ,vol. 71, pp. 495- 502 ,(2002) , 10.1189/JLB.71.3.495
Kumudha Balakrishnan, Jan A. Burger, William G. Wierda, Varsha Gandhi, AT-101 induces apoptosis in CLL B cells and overcomes stromal cell–mediated Mcl-1 induction and drug resistance Blood. ,vol. 113, pp. 149- 153 ,(2009) , 10.1182/BLOOD-2008-02-138560
Maike Buchner, Constance Baer, Gabriele Prinz, Christine Dierks, Meike Burger, Thorsten Zenz, Stephan Stilgenbauer, Hassan Jumaa, Hendrik Veelken, Katja Zirlik, Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia Blood. ,vol. 115, pp. 4497- 4506 ,(2009) , 10.1182/BLOOD-2009-07-233692
Gianluca Gaidano, Robin Foà, Riccardo Dalla-Favera, Molecular pathogenesis of chronic lymphocytic leukemia Journal of Clinical Investigation. ,vol. 122, pp. 3432- 3438 ,(2012) , 10.1172/JCI64101
Lisa Pleyer, Alexander Egle, Tanja Nicole Hartmann, Richard Greil, None, Molecular and cellular mechanisms of CLL: novel therapeutic approaches Nature Reviews Clinical Oncology. ,vol. 6, pp. 405- 418 ,(2009) , 10.1038/NRCLINONC.2009.72
Parisa Shooshtari, Edgardo S. Fortuno, Darren Blimkie, Miao Yu, Arvind Gupta, Tobias R. Kollmann, Ryan R. Brinkman, Correlation analysis of intracellular and secreted cytokines via the generalized integrated mean fluorescence intensity Cytometry Part A. ,vol. 77, pp. 873- 880 ,(2010) , 10.1002/CYTO.A.20943